ABOUT BRUDYLAB

ABOUT BRUDYLAB

Brudy's story is associated with research on the healthy effects of omega-3 polyunsaturated fatty acids on human health. In 1995, the first foods enriched with Omega-3 were put on the market in Europe (eggs and milk). In 1998, the development of Omega-3 molecules for medical dietary applications began. In 2001 we put on the market our fish oil enriched in DHA as triglyceride, with the trademark Tridocosahexaenoin-AOX® In 2010, the BRUDYLAB commercial division was created, which began the commercialization of food supplements and foods for special medical use for eye care, starting clinical research in all these areas. As of 2012, BRUDY expands its sales to Japan and Russia. In 2015 we began to publish the first results of clinical research in the ocular area: dry eye, glaucoma, diabetic retinopathy and also in sports, fertility, and we began research into new areas such as hepatology, neuropediatrics, obstetrics and neonatology. In 2017, the expansion to Mexico, Switzerland, Greece, the Czech and Slovak Republics began. In 2019 Italy and Brazil join. From 2010 to today we have published up to 30 clinical trials in the different areas of health, and at the moment we have another 6 trials underway. So far 25 years have been dedicated to the research of omega-3 fatty acids, at the service of human health.

OPHTALMOLOGY VADEMECUM

© 2015-2021 Brudy Lab, S.L.U | C/Ulises 108, 2º C - 28043 Madrid (Spain) - Phone number: +34 91 300 10 14 | info@brudylab.com | Legal Notice | Cookies | Quality policy